Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Acute kidney injury primary prevention
Introduction
Overview
Overview
Effective measures for the primary prevention of acute kidney injury include volume expansion and/or fluid therapy, optimization of blood pressure,tight glycemic control, avoidance of drug- and nephrotoxin-induced AKI, recheck renal function 48-72 hours following the radiological contrast media, and low doses of corticosteroids in septic shock patients.
Primary Prevention
Primary Prevention
- Effective measures for the primary prevention of acute kidney injury include:[1][2][3][4]
- Volume expansion and/or fluid therapy
- Optimization of blood pressure
- Tight glycemic control
- Avoidance of drug– and nephrotoxin-induced AKI
- Recheck renal function 48-72 hours following the radiological contrast media
- Low doses of corticosteroids in septic shock patients
References
References
- ↑ Kellum, John A; Leblanc, Martine; Gibney, R T. Noel; Tumlin, James; Lieberthal, Wilfred; Ronco, Claudio (2006). “Primary prevention of acute renal failure in the critically ill”. Current Opinion in Internal Medicine. 5 (1): 74–78. doi:10.1097/01.ccx.0000179934.76152.02. ISSN 1535-5942.
- ↑ Lameire, N.; Van Biesen, W.; Hoste, E.; Vanholder, R. (2008). “The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI”. Clinical Kidney Journal. 1 (6): 392–402. doi:10.1093/ndtplus/sfn162. ISSN 2048-8505.
- ↑ Harty J (September 2014). “Prevention and management of acute kidney injury”. Ulster Med J. 83 (3): 149–57. PMC 4255835. PMID 25484464.
- ↑ Park KM, Kramers C, Vayssier-Taussat M, Chen A, Bonventre JV (January 2002). “Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction”. J. Biol. Chem. 277 (3): 2040–9. doi:10.1074/jbc.M107525200. PMID 11696540.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]